Today, accelerating clinical trials to gain speed to market without compromising trial quality is the most critical aspect of success. However, the traditional clinical trial model isn’t always convenient for the patient, which can cause delays or failures in recruitment and enrollment. While a new model of decentralized clinical trials have been on the rise even before the pandemic of COVID-19, it comes with its own challenges such as:
Most clinical trials can be conducted at the patient’s home including studies with injections or intravenous drugs.
Download this infographic to learn more about the supply chain options for decentralized clinical trials.